ATE48278T1 - Verfahren zur herstellung von 2'desoxyadenosinverbindungen. - Google Patents

Verfahren zur herstellung von 2'desoxyadenosinverbindungen.

Info

Publication number
ATE48278T1
ATE48278T1 AT85108955T AT85108955T ATE48278T1 AT E48278 T1 ATE48278 T1 AT E48278T1 AT 85108955 T AT85108955 T AT 85108955T AT 85108955 T AT85108955 T AT 85108955T AT E48278 T1 ATE48278 T1 AT E48278T1
Authority
AT
Austria
Prior art keywords
desoxyadenosine
compounds
processes
preparation
deoxyadenosine
Prior art date
Application number
AT85108955T
Other languages
English (en)
Inventor
Roland Kenith Robins
Ganapathi Ramakrishna Revankar
Original Assignee
Univ Brigham Young
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Brigham Young filed Critical Univ Brigham Young
Application granted granted Critical
Publication of ATE48278T1 publication Critical patent/ATE48278T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT85108955T 1984-08-06 1985-07-17 Verfahren zur herstellung von 2'desoxyadenosinverbindungen. ATE48278T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63819284A 1984-08-06 1984-08-06
EP85108955A EP0173059B1 (de) 1984-08-06 1985-07-17 Verfahren zur Herstellung von 2'-Desoxyadenosinverbindungen

Publications (1)

Publication Number Publication Date
ATE48278T1 true ATE48278T1 (de) 1989-12-15

Family

ID=24559020

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85108955T ATE48278T1 (de) 1984-08-06 1985-07-17 Verfahren zur herstellung von 2'desoxyadenosinverbindungen.

Country Status (9)

Country Link
EP (1) EP0173059B1 (de)
JP (2) JPS61106594A (de)
AT (1) ATE48278T1 (de)
AU (1) AU572673B2 (de)
CA (1) CA1269659A (de)
DE (1) DE3574472D1 (de)
DK (1) DK165453C (de)
ES (1) ES8606383A1 (de)
ZA (1) ZA855696B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0217199A (ja) * 1988-07-05 1990-01-22 Japan Tobacco Inc 2’−デオキシ−β−アデノシンの製造方法
JPH02160799A (ja) * 1988-12-13 1990-06-20 Yuki Gosei Kogyo Co Ltd 2′−デオキシ−β−アデノシンの製造法
US5208327A (en) * 1991-12-18 1993-05-04 Ortho Pharmaceutical Corporation Intermediates useful in a synthesis of 2-chloro-2'-deoxyadenosine
WO2004028462A2 (en) * 2002-09-25 2004-04-08 Brigham Young University, Technology Transfer Office Method for the preparation of 2-halo-2'-deoxyadenosine compounds from 2'-deoxyguanosine
DK2805723T3 (da) 2004-12-22 2018-01-29 Merck Serono Sa Cladribin-regime til behandling af multipel sclerose
MX2008014971A (es) 2006-05-24 2008-12-05 Serono Lab Regimen de cladribine para tratar esclerosis multiple.
DE602006009282D1 (de) 2006-12-15 2009-10-29 Explora Lab Sa Verfahren zur Herstellung von Cladribin
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
CA2748057C (en) 2008-12-23 2018-07-03 Pharmasset, Inc. Nucleoside phosphoramidates
US8551973B2 (en) 2008-12-23 2013-10-08 Gilead Pharmasset Llc Nucleoside analogs
EP2376515A1 (de) 2008-12-23 2011-10-19 Pharmasset, Inc. Synthese von purinnukleosiden
US8232387B2 (en) 2009-08-18 2012-07-31 Scinopharm Taiwan, Ltd. Process for the preparation of cladribine
EP2343074A1 (de) 2009-12-23 2011-07-13 Merck Serono S.A. Verwendung von Purinanaloga zur Behandlung von Atemwegserkrankungen
WO2011113476A2 (en) 2010-03-16 2011-09-22 Cilag Ag Method for producing 2'-deoxyadenosine compounds
CL2011000718A1 (es) 2010-03-31 2012-04-09 Gilead Pharmasset Llc Proceso para la preparacion de compuestos fosforados enantiomericos.
GB201401465D0 (en) 2014-01-29 2014-03-12 Roach Arthur H Use of cladribine for treating autoimmune inflammatory disease
EP2993177A1 (de) 2014-09-05 2016-03-09 Technische Universität Berlin Chemoenzymatisches Herstellungsverfahren für Purinnucleosiden und deren Deaza- und Aza-Analoga
GB2564717A (en) 2017-07-21 2019-01-23 Chord Therapeutics S A R L Use of cladribine for treating autoimmune neuromuscular disease
CN111356460A (zh) 2017-11-24 2020-06-30 默克专利股份公司 用于治疗进展型形式的多发性硬化症的克拉屈滨疗法
CA3194812A1 (en) 2020-09-10 2022-03-17 Merck Patent Gmbh Novel treatment regimen for the treatment of autoimmune disorders
GB2601786A (en) 2020-12-10 2022-06-15 Chord Therapeutics S A R L Use of cladribine for treating immune brain disease
US20240077481A1 (en) 2021-03-03 2024-03-07 Ares Trading S.A. Improved treatment methods using dmds for the treatment of autoimmune diseases, and biomarker for predicting and/or optimising said treatment methods
DE102023123718A1 (de) 2023-09-04 2025-03-06 CHIRACON Pharma GmbH Verfahren zur Herstellung von Nukleosiden

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3225029A (en) * 1962-03-08 1965-12-21 Yamaoka Naotaka Process for the preparation of nucleosides and products obtained thereby
US3225008A (en) * 1962-05-21 1965-12-21 Scott Paper Co Itaconic esters of 1,2 alkane carbonates, polymers, and copolymers thereof
DE1795357A1 (de) * 1968-09-18 1972-01-05 Schering Ag 2-Thio-pyrimidin-nucleoside
CA1264738A (en) * 1984-12-04 1990-01-23 Eli Lilly And Company Treatment of tumors in mammals

Also Published As

Publication number Publication date
ES545888A0 (es) 1986-04-01
DK357585D0 (da) 1985-08-06
EP0173059A3 (en) 1987-04-29
ZA855696B (en) 1986-04-30
DK165453C (da) 1993-04-13
JPS61106594A (ja) 1986-05-24
ES8606383A1 (es) 1986-04-01
AU572673B2 (en) 1988-05-12
CA1269659A (en) 1990-05-29
EP0173059A2 (de) 1986-03-05
JPH02359B2 (de) 1990-01-08
DK357585A (da) 1986-02-07
DK165453B (da) 1992-11-30
AU4513885A (en) 1986-02-13
JPH0256497A (ja) 1990-02-26
EP0173059B1 (de) 1989-11-29
DE3574472D1 (de) 1990-01-04

Similar Documents

Publication Publication Date Title
ATE48278T1 (de) Verfahren zur herstellung von 2'desoxyadenosinverbindungen.
PT80440A (de) Verfahren zur herstellung von kristallinen natriumsilikaten
PT77122A (fr) Procede de preparation de derives de l'acide methylenediphosphonique
UA7088A1 (uk) Спосіб одержання солі 2-(2-гідроксіетоксі)етіламіна та 3,6-діхлор-2-метоксібензойної кислоти
OA06973A (fr) Procédé pour préparer enzymatiquement l'acide amino-2 méthylphosphino-4 butiryque- (L).
ATE49193T1 (de) Verfahren zur herstellung von (+)s-2-hydroxy-2methyl-hexans|ure.
IT8521215A0 (it) Processo per la preparazione dell'acido cis-5-fluoro-2-metil-1-(4-metiltiobenziliden)-indenil-3-acetico.
FR2559766B1 (fr) Procede de preparation de derives de l'acide carbamique
FR2570073B1 (fr) Procede de preparation d'acide 2,6-naphtalene-dicarboxylique
DE3677838D1 (de) Verfahren zur herstellung von alkylestern von 3,4-epoxybuttersaeure.
IT8420610A1 (it) "Procedimento per migliorare la crescita delle piante mediante illuminazione intermittente"
ATE43342T1 (de) Verfahren zur herstellung von hydrogeno- oder halogenosilanen.
HUT41375A (en) Process for producing cristalline glutaminic acid, first of all as monosodium salt, and process for producing salts and organic concentrate produced during the process
HUT36797A (en) Process for producing monosodium salt of 7-d-mandelamido-3-/1-sulfomethyl-tetrazol-5-y1-thio-methyl/-3-cepheme-4-carboxylic acid
EP0215949A4 (de) Herstellungsverfahren 16-substituierter prostaglandine-e.
DE3678487D1 (de) Verfahren zur herstellung von 6-amino-3-hydrazino-pyridazinderivaten.
IT1153750B (it) Processo per la preparazione dell'acido 3-carbossi-1-metilpirrol-2-acetico
FR2541993B1 (fr) Procede de preparation d'acide adipique
FR2507599B1 (fr) Procede de preparation de derives de sulfimide d'acide n-carbamoylbenzoique
FR2611743B1 (fr) Procede pour la production de l-aminoacides ou d'acide 5'-inosinique par fermentation
ATE6933T1 (de) Verfahren zur herstellung von 4aminobutters[ureamid.
FR2543948B1 (fr) Procede de preparation de l'acide 1-naphtol-4-sulfonique
IT7826498A0 (it) Processo per la preparazione di derivati dell'acido benzoxazolilpropionico.
RO92739A2 (ro) Procedeu de obtinere a acidului gluconic
IT8222454A0 (it) Preparazione di derivati dell'acido processo perfezionato per la benzoxazolil propionico.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time